Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new PubMed citation has been added to the Publications section: 'Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naive Patients with Chronic Spontaneous Urticaria' (Dermatol Ther (Heidelb), online ahead of print, 2025 Dec 2, doi:10.1007/s13555-025-01605-w). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-09T01:32:33.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications added to the Publications section include a 2025 article on dupilumab and CSU. The page also notes Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:01:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Deleted the general government funding operating-status notice from the page. The notice did not pertain to the study details or user actions.
    Difference
    0.2%
    Check dated 2025-11-17T18:13:59.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant additions or deletions are visible between the two screenshots. The page content, including study details and location listings, remains unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T12:50:07.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added a new version tag v3.2.0 along with an important notice about government funding and operating status of the NIH Clinical Center.
    Difference
    1%
    Check dated 2025-10-05T17:37:22.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Update includes a new version tag (v3.1.0) and removal of several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content scope reduction with a new release.
    Difference
    0.2%
    Check dated 2025-09-28T11:17:47.000Z thumbnail image

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.